Prevalence of substance misuse among individuals with severe mental illness in São Paulo

Social Psychiatry and Psychiatric Epidemiology

Volumn 39, Issue 3, 2004, Pages 212-217

  Menezes, Paulo Rossi ^a   Ratto, Lilian R C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cross sectional study; Dual diagnosis; Prevalence; Psychotic disorders; Substance use disorders

Indexed keywords

ALCOHOL; ILLICIT DRUG; NON PRESCRIPTION DRUG;

ADULT; ALCOHOLISM; ARTICLE; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CULTURAL FACTOR; DEVELOPING COUNTRY; DISEASE SEVERITY; DRUG DEPENDENCE; DRUG MISUSE; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MENTAL DISEASE; MENTAL HEALTH SERVICE; POLICY; PREVALENCE; PROBABILITY; PSYCHOSIS; SCHIZOPHRENIA; SCORING SYSTEM; SOCIAL ADAPTATION; STANDARDIZATION; SUBSTANCE ABUSE; SYMPTOMATOLOGY; URBAN POPULATION; ADDICTION; ADOLESCENT; BIPOLAR DISORDER; BRAZIL; CROSS-SECTIONAL STUDY; MIDDLE AGED; RESIDENTIAL CARE;

ADOLESCENT; ADULT; BIPOLAR DISORDER; BRAZIL; CATCHMENT AREA (HEALTH); CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SUBSTANCE-RELATED DISORDERS;

EID: 2342562468     PISSN: 09337954     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00127-004-0730-z     Document Type: Article

References (42)

1. Addington J, Addington D (1998) Effect of substance misuse in early psychosis. Br J Psychiatry 172:134-136
2. Almeida-Filho N, Mari J, Coutinho E, Franca JF, Fernandes J, Andreoli SB, Busnello ED (1997) Brazilian multicentric study of psychiatric morbidity. Methodological features and prevalence estimates. Br J Psychiatry 171:524-529
3. Andrade AG, Bassit AZ, Kerr-Corrêa F, Tonhon AA, Boscovitz EP, Cabral M, Rassi R, Potério GM, Marcondes E, Oliveira MPM, Duailibi K, Fukushima JT (1997) Fatores de risco associados ao uso de álcool e drogas na vida, entre estudantes de medicina do Estado de São Paulo. Rev ABP-APAL 19:117-126
4. Barry KL, Fleming MF, Greenley J, Widlak P, Kropp S, McKee D (1995) Assessment of alcohol and other drug disorders in the seriously mentally ill. Schizophr Bull 21:313-321
5. Bartels SJ, Teague GB, Drake RE, Clark RE, Bush PW, Noordsy DL (1993) Substance abuse in schizophrenia: service utilization and costs. J Nerv Ment Dis 181:227-232
6. Cuffel BJ, Shumway M, Chouljian TL, MacDonald T (1994) A longitudinal study of substance use and community violence in schizophrenia. J Nerv Ment Dis 182:704-708
7. Drake RE, Essock SM, Shaner A, Carey KB, Minkoff K, Kola L, Lynde D, Osher FC, Clark RE, Rickards L (2001) Implementing dual diagnosis services for clients with severe mental illness. Psychiatr Serv 52:469-476
8. Drake RE, Wallach MA (1989) Substance abuse among the chronic mentally-ill. Hosp Community Psychiatry 40:1041-1046
9. Drake RE, Wallach MA, Teague GB, Freeman DH, Paskus TS, Clark TA (1991) Housing instability and homelessness among rural schizophrenic patients. Am J Psychiatry 148:330-336
10. Duke PJ, Pantelis C, Barnes TR (1994) South Westminster schizophrenia survey. Alcohol use and its relationship to symptoms, tardive dyskinesia and illness onset. Br J Psychiatry 164:630-636
11. Duke PJ, Pantelis C, McPhillips MA, Barnes TR (2001) Comorbid non-alcohol substance misuse among people with schizophrenia: epidemiological study in central London. Br J Psychiatry 179:509-513
12. Galduroz JCF, Noto AR, Carlini EA (1997) IV levantamento sobre o uso de drogas entre estudantes de primeiro e segundo graus em 10 capitais brasileiras - 1997. CEBRID, São Paulo
13. Haywood TW, Kravitz HM, Grossman LS, Cavanaugh JL, Davis JM, Lewis DA (1995) Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. Am J Psychiatry 152:856-861
14. Heckert U, Andrade L, Alves MJ, Martins C (1999) Lifetime prevalence of mental disorders among homeless people in a southeast city in Brazil. Eur Arch Psychiatry Clin Neurosci 249:150-155
15. Isaac M, Bebbington PE (1991) Strategies for the management of severe psychiatric illness in the community. Int Rev Psychiatry 3:71-82
16. Janca A, Ustun TB, van Drimmelen J, Dittmann V, Isaac M (1994) ICD-10 symptom checklist for mental disorders, version 1.1. World Health Organization, Geneva
17. Jenkins R, Lewis G, Bebbington P, Brugha T, Farrell M, Gill B, Meltzer H (1997) The National Psychiatric Morbidity surveys of Great Britain - initial findings from the household survey. Psychol Med 27:775-789
18. Jerrell JM, Ridgely MS (1995) Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders. J Nerv Ment Dis 183:566-576
19. Johnson S (1997) Dual diagnosis of severe mental illness and substance misuse: a case for specialist services? Br J Psychiatry 171:205-208
20. Johnston LD, O'Malley PM, Bachman JG (2001) Monitoring the future national survey results on drug use, 1975-2000. US. Department of Health and Human Services, Bethesda
21. Kay SR, Opler LA, Lindenmayer JP (1988) Reliability and validity of the Positive and Negative Syndrome Scale for schizophrenics. Psychiatry Res 23:99-110
22. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51:8-19
23. Lehman AF, Herron JD, Schwartz RP, Myers CP (1993) Rehabilitation for adults with severe mental illness and substance use disorders. A clinical trial. J Nerv Ment Dis 181:86-90
24. Ley A, Jeffery DP, McLaren S, Siegfried N (2000) Treatment programmes for people with both severe mental illness and substance misuse. Cochrane Database Syst Rev CD001088
25. Linszen DH, Dingemans PM, Lenior ME (1994) Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry 51:273-279
26. Lysaker P, Bell M, Beamgoulet J, Milstein R (1994) Relationship of positive and negative symptoms to cocaine abuse in schizophrenia. J Nerv Ment Dis 182:109-112
27. McCrone P, Menezes PR, Johnson S, Scott H, Thornicroft G, Marshall J, Bebbington P, Kuipers E (2000) Service use and costs of people with dual diagnosis in South London. Acta Psychiatr Scand 101:464-472
28. Menezes PR, Johnson S, Thornicroft G, Marshall J, Prosser D, Bebbington P, Kuipers E (1996) Drug and alcohol problems among individuals with severe mental illness in south London. Br J Psychiatry 168:612-619
29. Osher FC, Drake RE, Noordsy DL, Teague GB, Hurlbut SC, Biesanz JC, Beaudett MS (1994) Correlates and outcomes of alcohol use disorder among rural outpatients with schizophrenia. J Clin Psychiatry 55:109-113
30. Owen RR, Fischer EP, Booth BM, Cuffel BJ (1996) Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatr Serv 47:853-858
31. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK (1990) Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264:2511-2518
32. Riley L, Marshall M (1999) Alcohol and public health in 8 developing countries. World Health Organization, Geneva
33. Salyers MP, Mueser KT (2001) Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia. Schizophr Res 48:109-123
34. Scott H, Johnson S, Menezes P, Thornicroft G, Marshall J, Bindman J, Bebbington P, Kuipers E (1998) Substance misuse and risk of aggression and offending among the severely mentally ill. Br J Psychiatry 172:345-350
35. SEADE (2002) PCV. 2001. Distribuição dos Indivíduos, segundo Condia̧ão de Posse de Convênio ou Plano de Saúde, Estado de São Paulo, RMSP e Interior, 1994-1998
36. Sullivan G, Wells KB, Morgenstern H, Leake B (1995) Identifying modifiable risk factors for rehospitalization: a case-control study of seriously mentally ill persons in Mississippi. Am J Psychiatry 152:1749-1756
37. Wallace CJ (1993) Psychiatric rehabilitation. Psychopharmacol Bull 29:537-548
38. Weaver T, Renton A, Stimson G, Tyrer P (1999) Severe mental illness and substance misuse. BMJ 318:137-138
39. World Health Organization (1988) Psychiatric Disability Assessment Schedule (WHO/DAS). WHO, Geneva
40. World Health Organization (1992a) The ICD-10 Classification of Mental and Behavioural Disorders. Clinical descriptions and diagnostic guidelines. WHO, Geneva
41. World Health Organization (1992b) Life Chart Rating Form. WHO, Geneva
42. World Health Organization (1994) Schedule for clinical assessment in neuropsychiatry. American Psychiatric Press, Geneva